4-(Chloromethyl)-2-(thiophen-2-yl)thiazole

Catalog No. :
ACAEBI751
CAS No. :
54679-16-2
Molecular Formula :
C8H6ClNS2
Molecular Weight :
215.73

IUPAC Name:4-(chloromethyl)-2-(thiophen-2-yl)thiazole

4-(Chloromethyl)-2-(thiophen-2-yl)thiazole structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$75.00Login to see priceInquiryInquiry
1g95%$131.00Login to see priceInquiryInquiry
5g95%$399.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-(Chloromethyl)-2-(thiophen-2-yl)thiazole
IUPAC Name4-(chloromethyl)-2-(thiophen-2-yl)thiazole
MDL No.MFCD01571296
Molecular FormulaC8H6ClNS2
Molecular Weight215.73
SMILESClCC1=CSC(C2=CC=CS2)=N1
InChI KeyCGJJBHKYGNSTDK-UHFFFAOYSA-N
Synonym4-(CHLOROMETHYL)-2-(2-THIENYL)-1,3-THIAZOLE;Thiazole,4-(chloroMethyl)-2-(2-thienyl)-;4-(Chloromethyl)-2-(thiophen-2-yl)-thiazole;4-(CHLOROMETHYL)-2-THIEN-2-YL-1,3-THIAZOLE;4-(Chloromethyl)-2-(2-thienyl)thiazole;4-(Chloromethyl)-2-(thiophen-2-yl)-1,3-thiazole
CAS No.54679-16-2

Safety Data

Pictogram
CorrosiveHarmful or irritant
Signal Word
Gefahr
Hazard Statement(s)
H302-H314
Precautionary Statement(s)
P264-P270-P271-P280-P303+P361+P353-P304+P340-P305+P351+P338-P310-P330-P331-P363-P403+P233-P501

Synthetic Route by SureRoute

1. ACAEBI751 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACAEBI751 route product structure diagram
    ACAEBI75154679-16-2
Inquiry

2. ACAEBI751 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACMHJE956 route compound structure diagram
    ACMHJE95620300-02-1 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACAEBI751 route product structure diagram
    ACAEBI75154679-16-2
Inquiry

Comments (0)